Skip to main content

Table 2 Clinical characteristics of patients included.

From: The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients

  Crohn's disease Ulcerative colitis
Number 68 24
Disease duration (months) 27 (0-268) 11 (1-188)
Outpatients 61 (90%) 16 (67%)
Previous hospitalizations 2 (0-14) 2 (0-6)
Previous resective surgery 33 (49%) -
Localization   
   L1: Terminal ileum 28 (41%)  
   L2: Colon 21 (31%)  
   L3: Ileocolon 15 (22%)  
   L4: Upper gastrointestinal 4 (6%)  
   E1: Ulcerative proctitis   2 (8%)
   E2: Left-sided Ulcerative colitis   7 (29%)
   E3: Extensive Ulcerative colitis   15 (63%)
Behavior   
   B1: inflammatory 27 (40%)  
   B2: stricturing 26 (38%)  
   B3: penetrating 15 (22%)  
Perianal disease 24 (35%) 1 (4%)
Indication of treatment   
   Steroid dependence 24 (35%) 15 (62%)
   Induction of remission 10 (15%) 5 (21%)
   Maintenance after severe flare 1 (1%) 4 (17%)
   Fistulizing disease 8 (12%) -
   Prevention of recurrence 21 (31%) -
   Extensive disease 4 (6%) -
Concomitant treatment   
   Steroids 35 (52%) 17 (71%)
   Infliximab 8 (12%) -
   Antibiotics 18 (27%) 1 (4%)
   Mesalamine 2 (3%) 5 (21%)
   Topical treatment 1 (2%) 19 (79%)
  1. Results are expressed as medians and range or absolute value and percentage.